Summary
Dr. Reddy’s had announced that it has signed a collaboration agreement with Alvotech to co-develop the biosimilar candidate to Keytruda or Pembrolizumab.
Source: CNBCTV18
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
